Brief: Sygnis plans to acquire Innova Biosciences Ltd.
Brief: Sygnis FY net loss widens to 4.4 million euros
Brief: Sygnis completes second contract with China's TANON
Brief: Sygnis anounces change in guarantee for Spanish government soft loans
Brief: Sygnis says David Roth appointed CFO
Brief: Sygnis buys C.B.S. Scientific for us $0.9 mln
Brief: Sygnis: two patents granted in Europe and China
Brief: Sygnis 9-mth net loss shrinks to 2.14 million euros
Brief: Sygnis says to receive 1.9 million euros R&D funding from Spanish government
Brief: SYGNIS enters into collaboration agreement with ECACC for licensing and distribution of Caco-2 cell line
CEO and Chief Scientific Officer
Brief: Sygnis H1 revenues up by 63% to 319 thousand euros
Brief: Sygnis completes rights offering and private placement
Brief: Sygnis successfully completes rights offering and private placement
Brief: Sygnis: global launch of Trueprime Single Cell WGA Kit V2
Brief: Sygnis says investor pledges to buy shares in capital hike
Brief: Sygnis announces new tool for detection and amplification of cell-free DNA in blood
Brief: Sygnis AG Q1 revenues up by 20% to 91 thousand euros
Brief: Sygnis plans to acquire Expedeon Holdings Ltd